CD44-DT: A Drug Target / Disease Biomarker (G100507144)
CD44-DT: A Drug Target / Disease Biomarker
CD44-DT is a protein that is expressed in various tissues throughout the body, including the lungs, heart, kidneys, and gastrointestinal tract. It is a member of the CD44 family, which is known for its role in cell-cell adhesion and signaling. CD44-DT has been shown to be involved in a number of biological processes, including cell proliferation, migration, and survival.
One of the most promising aspects of CD44-DT is its potential as a drug target. Because it is involved in so many different processes in the body, it is a promising target for the development of new treatments for a wide range of diseases. For example, CD44-DT has been shown to be involved in cancer cell growth and metastasis, and may be a useful target for cancer treatments.
In addition to its potential as a drug target, CD44-DT has also been shown to be a useful biomarker for certain diseases. For example, it has been shown to be elevated in the blood of people with heart disease, and may be a useful indicator of the severity of this condition. It has also been shown to be elevated in the urine of people with kidney disease, and may be a useful indicator of the severity of this condition.
CD44-DT is also of interest to researchers because of its complex structure. The CD44 protein is composed of several hundred amino acids, and is known for its ability to form a tight, linear dimer in solution. This structure makes it difficult to study, and has presented a challenge for researchers trying to understand its function. However, recent studies have shown that CD44-DT is involved in a number of complex cellular processes, including cell-cell adhesion and signaling.
In conclusion, CD44-DT is a protein that is expressed in various tissues throughout the body, and is involved in a number of different biological processes. Its potential as a drug target and biomarker make it an attractive target for the development of new treatments for a wide range of diseases. Further research is needed to fully understand its function and potential as a drug.
Protein Name: CD44 Divergent Transcript
The "CD44-DT Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about CD44-DT comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
CD46 | CD47 | CD48 | CD5 | CD52 | CD53 | CD55 | CD58 | CD59 | CD5L | CD6 | CD63 | CD68 | CD69 | CD7 | CD70 | CD72 | CD74 | CD79A | CD79B | CD8 | CD80 | CD81 | CD81-AS1 | CD82 | CD83 | CD84 | CD86 | CD8A | CD8B | CD8B2 | CD9 | CD93 | CD96 | CD99 | CD99L2 | CD99P1 | CDA | CDADC1 | CDAN1 | CDC123 | CDC14A | CDC14B | CDC14C | CDC16 | CDC20 | CDC20-DT | CDC20B | CDC20P1 | CDC23 | CDC25A | CDC25B | CDC25C | CDC26 | CDC27 | CDC27P2 | CDC34 | CDC37 | CDC37L1 | CDC37P1 | CDC40 | CDC42 | CDC42BPA | CDC42BPB | CDC42BPG | CDC42EP1 | CDC42EP2 | CDC42EP3 | CDC42EP4 | CDC42EP5 | CDC42SE1 | CDC42SE2 | CDC45 | CDC5L | CDC5L complex | CDC6 | CDC7 | CDC73 | CDCA2 | CDCA3 | CDCA4 | CDCA4P3 | CDCA5 | CDCA7 | CDCA7L | CDCA8 | CDCP1 | CDCP2 | CDH1 | CDH10 | CDH11 | CDH12 | CDH13 | CDH13-AS2 | CDH15 | CDH16 | CDH17 | CDH18 | CDH19 | CDH2
